Emmanuelle Bourbouloux

Nantes, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Prospective SAJAC Study of Rehabilitation for Adolescents and Young Adults with Cancer in a Comprehensive Cancer Center.

Prospective SAJAC Study of Rehabilitation for Adolescents and Young Adults with Cancer in a Comprehensive Cancer Center.

Journal: Journal of adolescent and young adult oncology

Published: July 07, 2026

Melatonin supplementation for quality of life in older patients with advanced cancer: a randomized controlled trial.

Melatonin supplementation for quality of life in older patients with advanced cancer: a randomized controlled trial.

Journal: BMC geriatrics

Published: May 26, 2025

Important aspects of care and priorities of older patients with cancer: The PRIORITY multicenter cohort study.

Important aspects of care and priorities of older patients with cancer: The PRIORITY multicenter cohort study.

Journal: Journal of geriatric oncology

Published: May 06, 2025

Important aspects of care and priorities of older patients with cancer: The PRIORITY multicenter cohort study.

Important aspects of care and priorities of older patients with cancer: The PRIORITY multicenter cohort study.

Journal: Journal of geriatric oncology

Published: May 06, 2025

Home-based supervised exercise on metastatic cancer patients receiving oral targeted therapy: the AFSOS-Unicancer QUALIOR randomized phase 2 study.

Home-based supervised exercise on metastatic cancer patients receiving oral targeted therapy: the AFSOS-Unicancer QUALIOR randomized phase 2 study.

Journal: The oncologist

Published: January 09, 2025

Adjuvant chemotherapy and hormonotherapy versus adjuvant hormonotherapy alone for women aged 70 years and older with high-risk breast cancer based on the genomic grade index (ASTER 70s): a randomised phase 3 trial.

Adjuvant chemotherapy and hormonotherapy versus adjuvant hormonotherapy alone for women aged 70 years and older with high-risk breast cancer based on the genomic grade index (ASTER 70s): a randomised phase 3 trial.

Journal: Lancet (London, England)

Published: November 26, 2024

Evaluating everolimus for the treatment of breast cancer.

Evaluating everolimus for the treatment of breast cancer.

Journal: Expert opinion on pharmacotherapy

Published: May 15, 2023

Cognitive change in breast cancer patients up to 2 years after diagnosis.

Cognitive change in breast cancer patients up to 2 years after diagnosis.

Journal: Journal of the National Cancer Institute

Published: August 11, 2022

Efficacy and Safety of First-line Single-Agent Carboplatin vs Carboplatin Plus Paclitaxel for Vulnerable Older Adult Women With Ovarian Cancer: A GINECO/GCIG Randomized Clinical Trial.

Efficacy and Safety of First-line Single-Agent Carboplatin vs Carboplatin Plus Paclitaxel for Vulnerable Older Adult Women With Ovarian Cancer: A GINECO/GCIG Randomized Clinical Trial.

Journal: JAMA oncology

Published: April 22, 2021

French translation and adaptation of the "Return to Work Self-Efficacy' Scale - 11 items" in patients diagnosed with a cancer

French translation and adaptation of the "Return to Work Self-Efficacy' Scale - 11 items" in patients diagnosed with a cancer

Journal: Bulletin du cancer

Published: March 30, 2021

Benefits versus risk profile of buparlisib for the treatment of breast cancer.

Benefits versus risk profile of buparlisib for the treatment of breast cancer.

Journal: Expert opinion on drug safety

Published: June 05, 2019

Pertuzumab for the treatment of breast cancer.

Pertuzumab for the treatment of breast cancer.

Journal: Expert review of anticancer therapy

Published: March 20, 2019

Showing 1-12 of 38

Last Updated: 09/26/2026